首页 > 最新文献

JTCVS open最新文献

英文 中文
RBT-1 Reduces Blood Product Utilization in Patients Undergoing Non-Emergent Coronary Artery Bypass Grafting and/or Valve Surgery RBT-1 可减少接受非急诊冠状动脉旁路移植术和/或瓣膜手术患者的血液制品使用量
Pub Date : 2024-07-01 DOI: 10.1016/j.xjon.2024.06.019
Charles A. Mack, M. Jessen, Andre Lamy, Ashish Khanna, Kevin Lobdell, Rakesh Arora, Jeannette Rodriguez, Stacey Ruiz, Bhupinder Singh
{"title":"RBT-1 Reduces Blood Product Utilization in Patients Undergoing Non-Emergent Coronary Artery Bypass Grafting and/or Valve Surgery","authors":"Charles A. Mack, M. Jessen, Andre Lamy, Ashish Khanna, Kevin Lobdell, Rakesh Arora, Jeannette Rodriguez, Stacey Ruiz, Bhupinder Singh","doi":"10.1016/j.xjon.2024.06.019","DOIUrl":"https://doi.org/10.1016/j.xjon.2024.06.019","url":null,"abstract":"","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141696725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An evaluation of the outcomes associated with peritoneal catheter use in neonates undergoing cardiac surgery: A multicenter study 对接受心脏手术的新生儿使用腹膜导管的相关结果进行评估:一项多中心研究
Pub Date : 2024-06-01 DOI: 10.1016/j.xjon.2024.03.009
David M. Kwiatkowski MD, MS , Jeffrey A. Alten MD , Kenneth E. Mah MD , David T. Selewski MD , Tia T. Raymond MD, MBA , Natasha S. Afonso MD, MPH , Joshua J. Blinder MD , Matthew T. Coghill MD , David S. Cooper MD, MPH , Joshua D. Koch MD , Catherine D. Krawczeski MD , David L.S. Morales MD , Tara M. Neumayr MD , A.K.M. Fazlur Rahman PhD , Garrett Reichle MS , Sarah Tabbutt MD, PhD , Tennille N. Webb MD , Santiago Borasino MD

Objective

The study objective was to determine if intraoperative peritoneal catheter placement is associated with improved outcomes in neonates undergoing high-risk cardiac surgery with cardiopulmonary bypass.

Methods

This propensity score–matched retrospective study used data from 22 academic pediatric cardiac intensive care units. Consecutive neonates undergoing Society of Thoracic Surgeons–European Association for Cardio-Thoracic Surgery category 3 to 5 cardiac surgery with cardiopulmonary bypass at centers participating in the NEonatal and Pediatric Heart Renal Outcomes Network collaborative were studied to determine the association of the use of an intraoperative placed peritoneal catheter for dialysis or passive drainage with clinical outcomes, including the duration of mechanical ventilation.

Results

Among 1490 eligible neonates in the NEonatal and Pediatric Heart Renal Outcomes Network dataset, a propensity-matched analysis was used to compare 395 patients with peritoneal catheter placement with 628 patients without peritoneal catheter placement. Time to extubation and most clinical outcomes were similar. Postoperative length of stay was 5 days longer in the peritoneal catheter placement cohort (17 vs 22 days, P = .001). There was a 50% higher incidence of moderate to severe acute kidney injury in the no-peritoneal catheter cohort (12% vs 18%, P = .02). Subgroup analyses between specific treatments and in highest risk patients yielded similar associations.

Conclusions

This study does not demonstrate improved outcomes among neonates with placement of a peritoneal catheter during cardiac surgery. Outcomes were similar apart from longer hospital stay in the peritoneal catheter cohort. The no-peritoneal catheter cohort had a 50% higher incidence of moderate to severe acute kidney injury (12% vs 18%). This analysis does not support indiscriminate peritoneal catheter use, although it may support the utility for postoperative fluid removal among neonates at risk for acute kidney injury. A multicenter controlled trial may better elucidate peritoneal catheter effects.

研究目的是确定术中腹腔导管置入是否与接受心肺旁路高风险心脏手术的新生儿预后改善有关。方法这项倾向评分匹配回顾性研究使用了来自 22 家学术性儿科心脏重症监护病房的数据。在参与东北产科和儿科心脏肾脏结果网络合作研究的中心,连续有新生儿接受胸外科医师协会-欧洲心胸外科学会 3-5 类心脏手术并进行心肺旁路手术,研究旨在确定术中放置腹膜透析导管或被动引流导管与临床结果(包括机械通气持续时间)之间的关系。结果在东北产科和儿科心脏肾脏结果网络数据集中的1490名符合条件的新生儿中,采用倾向匹配分析比较了395名置入腹膜导管的患者和628名未置入腹膜导管的患者。拔管时间和大多数临床结果相似。腹腔导管置入组患者的术后住院时间延长了 5 天(17 天 vs 22 天,P = .001)。未放置腹膜导管队列中中度至重度急性肾损伤的发生率比放置腹膜导管队列高 50%(12% 对 18%,P = .02)。对特定治疗方法和高风险患者进行亚组分析,也得出了类似的结论。腹腔导管组除了住院时间较长之外,其他结果相似。未使用腹膜导管组的中重度急性肾损伤发生率高出 50%(12% 对 18%)。这项分析并不支持不加选择地使用腹腔导管,不过它可能支持在有急性肾损伤风险的新生儿术后排液时使用腹腔导管。多中心对照试验可更好地阐明腹膜导管的作用。
{"title":"An evaluation of the outcomes associated with peritoneal catheter use in neonates undergoing cardiac surgery: A multicenter study","authors":"David M. Kwiatkowski MD, MS ,&nbsp;Jeffrey A. Alten MD ,&nbsp;Kenneth E. Mah MD ,&nbsp;David T. Selewski MD ,&nbsp;Tia T. Raymond MD, MBA ,&nbsp;Natasha S. Afonso MD, MPH ,&nbsp;Joshua J. Blinder MD ,&nbsp;Matthew T. Coghill MD ,&nbsp;David S. Cooper MD, MPH ,&nbsp;Joshua D. Koch MD ,&nbsp;Catherine D. Krawczeski MD ,&nbsp;David L.S. Morales MD ,&nbsp;Tara M. Neumayr MD ,&nbsp;A.K.M. Fazlur Rahman PhD ,&nbsp;Garrett Reichle MS ,&nbsp;Sarah Tabbutt MD, PhD ,&nbsp;Tennille N. Webb MD ,&nbsp;Santiago Borasino MD","doi":"10.1016/j.xjon.2024.03.009","DOIUrl":"10.1016/j.xjon.2024.03.009","url":null,"abstract":"<div><h3>Objective</h3><p>The study objective was to determine if intraoperative peritoneal catheter placement is associated with improved outcomes in neonates undergoing high-risk cardiac surgery with cardiopulmonary bypass.</p></div><div><h3>Methods</h3><p>This propensity score–matched retrospective study used data from 22 academic pediatric cardiac intensive care units. Consecutive neonates undergoing Society of Thoracic Surgeons–European Association for Cardio-Thoracic Surgery category 3 to 5 cardiac surgery with cardiopulmonary bypass at centers participating in the NEonatal and Pediatric Heart Renal Outcomes Network collaborative were studied to determine the association of the use of an intraoperative placed peritoneal catheter for dialysis or passive drainage with clinical outcomes, including the duration of mechanical ventilation.</p></div><div><h3>Results</h3><p>Among 1490 eligible neonates in the NEonatal and Pediatric Heart Renal Outcomes Network dataset, a propensity-matched analysis was used to compare 395 patients with peritoneal catheter placement with 628 patients without peritoneal catheter placement. Time to extubation and most clinical outcomes were similar. Postoperative length of stay was 5 days longer in the peritoneal catheter placement cohort (17 vs 22 days, <em>P</em> = .001). There was a 50% higher incidence of moderate to severe acute kidney injury in the no-peritoneal catheter cohort (12% vs 18%, <em>P</em> = .02). Subgroup analyses between specific treatments and in highest risk patients yielded similar associations.</p></div><div><h3>Conclusions</h3><p>This study does not demonstrate improved outcomes among neonates with placement of a peritoneal catheter during cardiac surgery. Outcomes were similar apart from longer hospital stay in the peritoneal catheter cohort. The no-peritoneal catheter cohort had a 50% higher incidence of moderate to severe acute kidney injury (12% vs 18%). This analysis does not support indiscriminate peritoneal catheter use, although it may support the utility for postoperative fluid removal among neonates at risk for acute kidney injury. A multicenter controlled trial may better elucidate peritoneal catheter effects.</p></div>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666273624000688/pdfft?md5=c36f936319a101fe5d6c4b4f8d96cfa9&pid=1-s2.0-S2666273624000688-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140399684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term outcomes of surgical or endovascular treatment of adult with midaortic syndrome: A single-center retrospective study over a 14-year period 手术或血管内治疗成人大动脉综合征的长期疗效
Pub Date : 2024-06-01 DOI: 10.1016/j.xjon.2024.03.011
Hao Liu MD, PhD , Tianyue Pan MD, PhD , Bin Chen MD, PhD , Junhao Jiang MD, PhD , Weiguo Fu MD, PhD , Zhihui Dong MD, PhD

Objective

Midaortic syndrome is a rare clinical condition that has been mainly studied in juveniles through case reports and series. This study aims to report the anatomic characteristics and long-term outcomes of 41 adult patients with midaortic syndrome who received open surgical treatment or endovascular treatment over a 14-year period.

Methods

A consecutive cohort of 41 adult patients diagnosed with midaortic syndrome at our center between January 2008 and November 2021 were enrolled in the study. Patients’ baseline and anatomic characteristics were collected and analyzed. Primary follow-up outcomes included death and reintervention. Other follow-up outcomes included hypertension and complications.

Results

The study enrolled 41 adult patients with midaortic syndrome with a mean age of 37.5 ± 13.4 years. Twenty-five patients received open surgical treatment, and 16 patients received endovascular treatment. Isolated infrarenal lesions were more likely to be found in the endovascular treatment group (P = .005), whereas patients with multiple (P = .002) or intravisceral involvement (P = .001) were more likely to be found in the open surgical treatment group. The open surgical treatment group was more likely to have a lower postoperative peak systolic pressure gradient (P = .020). The 5- and 10-year reintervention-free survivals were 87.7% and 71.7% in the open surgical treatment group and 92.3% and 79.1% in the endovascular treatment group, respectively.

Conclusions

Both open surgical treatment and endovascular treatment showed satisfactory long-term efficacy outcomes for adult patients with midaortic syndrome. Given the patients’ relatively young age and long life expectancy, strict and regular lifelong follow-up is necessary.

目的主动脉夹层综合征是一种罕见的临床病症,主要通过病例报告和系列研究对青少年进行研究。本研究旨在报告 41 名成年中主动脉综合征患者在 14 年间接受开放手术治疗或血管内治疗的解剖学特征和长期疗效。 研究方法:本中心连续纳入了 2008 年 1 月至 2021 年 11 月间诊断为中主动脉综合征的 41 名成年患者。收集并分析了患者的基线和解剖特征。主要随访结果包括死亡和再次介入治疗。其他随访结果包括高血压和并发症。结果该研究共纳入41名成年中主动脉综合征患者,平均年龄(37.5 ± 13.4)岁。25名患者接受了开放手术治疗,16名患者接受了血管内治疗。血管内治疗组更容易发现孤立的肾下病变(P = .005),而开放手术治疗组更容易发现多发(P = .002)或内脏受累(P = .001)的患者。开放手术治疗组术后收缩压阶差峰值更低(P = .020)。开放手术治疗组的 5 年和 10 年无再介入存活率分别为 87.7% 和 71.7%,而血管内治疗组的 5 年和 10 年无再介入存活率分别为 92.3% 和 79.1%。鉴于患者年龄相对较小,预期寿命较长,有必要进行严格、定期的终身随访。
{"title":"Long-term outcomes of surgical or endovascular treatment of adult with midaortic syndrome: A single-center retrospective study over a 14-year period","authors":"Hao Liu MD, PhD ,&nbsp;Tianyue Pan MD, PhD ,&nbsp;Bin Chen MD, PhD ,&nbsp;Junhao Jiang MD, PhD ,&nbsp;Weiguo Fu MD, PhD ,&nbsp;Zhihui Dong MD, PhD","doi":"10.1016/j.xjon.2024.03.011","DOIUrl":"10.1016/j.xjon.2024.03.011","url":null,"abstract":"<div><h3>Objective</h3><p>Midaortic syndrome is a rare clinical condition that has been mainly studied in juveniles through case reports and series. This study aims to report the anatomic characteristics and long-term outcomes of 41 adult patients with midaortic syndrome who received open surgical treatment or endovascular treatment over a 14-year period.</p></div><div><h3>Methods</h3><p>A consecutive cohort of 41 adult patients diagnosed with midaortic syndrome at our center between January 2008 and November 2021 were enrolled in the study. Patients’ baseline and anatomic characteristics were collected and analyzed. Primary follow-up outcomes included death and reintervention. Other follow-up outcomes included hypertension and complications.</p></div><div><h3>Results</h3><p>The study enrolled 41 adult patients with midaortic syndrome with a mean age of 37.5 ± 13.4 years. Twenty-five patients received open surgical treatment, and 16 patients received endovascular treatment. Isolated infrarenal lesions were more likely to be found in the endovascular treatment group (<em>P = .</em>005), whereas patients with multiple (<em>P = .</em>002) or intravisceral involvement (<em>P = .</em>001) were more likely to be found in the open surgical treatment group. The open surgical treatment group was more likely to have a lower postoperative peak systolic pressure gradient (<em>P = .</em>020). The 5- and 10-year reintervention-free survivals were 87.7% and 71.7% in the open surgical treatment group and 92.3% and 79.1% in the endovascular treatment group, respectively.</p></div><div><h3>Conclusions</h3><p>Both open surgical treatment and endovascular treatment showed satisfactory long-term efficacy outcomes for adult patients with midaortic syndrome. Given the patients’ relatively young age and long life expectancy, strict and regular lifelong follow-up is necessary.</p></div>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666273624000901/pdfft?md5=c66160fa35c72c9abeb3ef82a7d4063b&pid=1-s2.0-S2666273624000901-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140401330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Left ventricular reverse remodeling after aortic valve replacement or repair in bicuspid aortic valve with moderate or greater aortic regurgitation 二尖瓣主动脉瓣置换或修复术后左心室反向重塑,主动脉瓣中度或重度反流
Pub Date : 2024-06-01 DOI: 10.1016/j.xjon.2024.03.006
Jonathan D. Kochav MD , Hiroo Takayama MD, PhD , Andrew Goldstone MD, PhD , David Kalfa MD, PhD , Emile Bacha MD , Marlon Rosenbaum MD , Matthew J. Lewis MD, MPH

Objective

Bicuspid aortic valve (AV) patients with aortic regurgitation (AR) differ from tricuspid AV patients given younger age, greater left ventricle (LV) compliance, and more prevalent aortic stenosis (AS). Bicuspid AV-specific data to guide timing of AV replacement or repair are lacking.

Methods

Adults with bicuspid AV and moderate or greater AR who underwent aortic valve replacement or repair at our center were studied. The presurgical echocardiogram, and echocardiograms within 3 years postoperatively were evaluated for LV geometry/function, and AV function. Semiquantitative AS/AR assessment was performed in all patients with adequate imaging.

Results

One hundred thirty-five patients (85% men, aged 44.5 ± 15.9 years) were studied (63% pure AR, 37% mixed AS/AR). Following aortic valve replacement or repair, change in LV end-diastolic dimension and change in LV end-diastolic volume were associated with preoperative LV end-diastolic dimension (β = 0.62 Δcm/cm; 95% CI, 0.43-0.73 Δcm/cm; P < .001), and LV end-diastolic volume (β = 0.6 ΔmL/mL; 95% CI, 0.4-0.7 ΔmL/mL; P < .001), respectively, each independent of AR/AS severity (P = not significant). Baseline LV size predicted postoperative normalization (LV end-diastolic dimension: odds ratio, 3.75/cm; 95% CI, 1.61-8.75/cm, LV end-diastolic volume: odds ratio, 1.01/mL; 95% CI, 1.004-1.019/mL, both P values < .01) whereas AR/AS severity did not (P = not significant). Indexed LV end diastolic volume outperformed LV end-diastolic dimension in predicting postoperative LV normalization (area under the curve = 0.74 vs 0.61) with optimal diagnostic cutoffs of 99 mL/m2 and 6.1 cm, respectively. Postoperative indexed LV end diastolic volume dilatation was associated with increased risk of death, transplant/ventricular assist device, ventricular arrhythmia, and reoperation (hazard ratio, 6.1; 95% CI, 1.7-21.5; P < .01).

Conclusions

Remodeling extent following surgery in patients with bicuspid AV and AR relates to preoperative LV size independent of valve disease phenotype or severity. Many patients with LV end-diastolic dimension below current surgical thresholds did not normalize LV size. LV volumetric assessment offered superior diagnostic performance for predicting residual LV dilatation, and postoperative indexed LV end diastolic volume dilatation was associated with adverse prognosis.

目的伴有主动脉瓣反流(AR)的双尖瓣主动脉瓣(AV)患者与三尖瓣主动脉瓣(AV)患者不同,因为他们的年龄更小、左心室(LV)顺应性更大、主动脉瓣狭窄(AS)更普遍。方法研究了在本中心接受主动脉瓣置换或修复手术的双尖瓣 AV 和中度或以上 AR 成人。对手术前超声心动图和术后 3 年内的超声心动图进行评估,以了解左心室的几何形状/功能和房室功能。结果 研究了 135 名患者(85% 为男性,年龄为 44.5 ± 15.9 岁)(63% 为纯粹的 AR,37% 为 AS/AR 混合型)。主动脉瓣置换或修补术后,左心室舒张末期尺寸的变化和左心室舒张末期容积的变化与术前左心室舒张末期尺寸相关(β = 0.62 Δcm/cm;95% CI,0.43-0.73 Δcm/cm;P <;.001)和 LV 舒张末期容积(β = 0.6 ΔmL/mL;95% CI,0.4-0.7 ΔmL/mL;P <;.001)相关,两者分别与 AR/AS 严重程度无关(P = 无显著性)。基线左心室大小可预测术后正常化(左心室舒张末期尺寸:几率比,3.75/cm;95% CI,1.61-8.75/cm;左心室舒张末期容积:几率比,1.01/mL;95% CI,1.004-1.019/mL,P值均为0.01),而AR/AS严重程度则不能预测术后正常化(P = 无学意义)。在预测术后左心室正常化方面,指数化左心室舒张末期容积优于左心室舒张末期尺寸(曲线下面积 = 0.74 vs 0.61),最佳诊断临界值分别为 99 mL/m2 和 6.1 cm。术后指数化左心室舒张末期容积扩张与死亡、移植/心室辅助装置、室性心律失常和再次手术的风险增加有关(危险比,6.1;95% CI,1.7-21.5;P < .01)。结论双尖瓣 AV 和 AR 患者术后的重塑程度与术前左心室大小有关,与瓣膜疾病的表型或严重程度无关。许多患者的左心室舒张末期尺寸低于目前的手术阈值,但其左心室尺寸并未恢复正常。左心室容积评估为预测残余左心室扩张提供了更优越的诊断性能,术后指数化左心室舒张末期容积扩张与不良预后相关。
{"title":"Left ventricular reverse remodeling after aortic valve replacement or repair in bicuspid aortic valve with moderate or greater aortic regurgitation","authors":"Jonathan D. Kochav MD ,&nbsp;Hiroo Takayama MD, PhD ,&nbsp;Andrew Goldstone MD, PhD ,&nbsp;David Kalfa MD, PhD ,&nbsp;Emile Bacha MD ,&nbsp;Marlon Rosenbaum MD ,&nbsp;Matthew J. Lewis MD, MPH","doi":"10.1016/j.xjon.2024.03.006","DOIUrl":"10.1016/j.xjon.2024.03.006","url":null,"abstract":"<div><h3>Objective</h3><p>Bicuspid aortic valve (AV) patients with aortic regurgitation (AR) differ from tricuspid AV patients given younger age, greater left ventricle (LV) compliance, and more prevalent aortic stenosis (AS). Bicuspid AV-specific data to guide timing of AV replacement or repair are lacking.</p></div><div><h3>Methods</h3><p>Adults with bicuspid AV and moderate or greater AR who underwent aortic valve replacement or repair at our center were studied. The presurgical echocardiogram, and echocardiograms within 3 years postoperatively were evaluated for LV geometry/function, and AV function. Semiquantitative AS/AR assessment was performed in all patients with adequate imaging.</p></div><div><h3>Results</h3><p>One hundred thirty-five patients (85% men, aged 44.5 ± 15.9 years) were studied (63% pure AR, 37% mixed AS/AR). Following aortic valve replacement or repair, change in LV end-diastolic dimension and change in LV end-diastolic volume were associated with preoperative LV end-diastolic dimension (β = 0.62 Δcm/cm; 95% CI, 0.43-0.73 Δcm/cm; <em>P</em> &lt; .001), and LV end-diastolic volume (β = 0.6 ΔmL/mL; 95% CI, 0.4-0.7 ΔmL/mL; <em>P</em> &lt; .001), respectively, each independent of AR/AS severity (<em>P</em> = not significant). Baseline LV size predicted postoperative normalization (LV end-diastolic dimension: odds ratio, 3.75/cm; 95% CI, 1.61-8.75/cm, LV end-diastolic volume: odds ratio, 1.01/mL; 95% CI, 1.004-1.019/mL, both <em>P</em> values &lt; .01) whereas AR/AS severity did not (<em>P</em> = not significant). Indexed LV end diastolic volume outperformed LV end-diastolic dimension in predicting postoperative LV normalization (area under the curve = 0.74 vs 0.61) with optimal diagnostic cutoffs of 99 mL/m<sup>2</sup> and 6.1 cm, respectively. Postoperative indexed LV end diastolic volume dilatation was associated with increased risk of death, transplant/ventricular assist device, ventricular arrhythmia, and reoperation (hazard ratio, 6.1; 95% CI, 1.7-21.5; <em>P</em> &lt; .01).</p></div><div><h3>Conclusions</h3><p>Remodeling extent following surgery in patients with bicuspid AV and AR relates to preoperative LV size independent of valve disease phenotype or severity. Many patients with LV end-diastolic dimension below current surgical thresholds did not normalize LV size. LV volumetric assessment offered superior diagnostic performance for predicting residual LV dilatation, and postoperative indexed LV end diastolic volume dilatation was associated with adverse prognosis.</p></div>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666273624000652/pdfft?md5=228f2024c58b19ea8c78046c1a5112de&pid=1-s2.0-S2666273624000652-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140402467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thoracic aortic surgery in low- and middle-income countries: Time to bridge the gap? 中低收入国家的胸主动脉手术:缩小差距的时机已到?
Pub Date : 2024-06-01 DOI: 10.1016/j.xjon.2024.03.002
Dominique Vervoort MD, MPH, MBA , Dimitri Tchienga MD , Maral Ouzounian MD, PhD , Charles Mve Mvondo MD
{"title":"Thoracic aortic surgery in low- and middle-income countries: Time to bridge the gap?","authors":"Dominique Vervoort MD, MPH, MBA ,&nbsp;Dimitri Tchienga MD ,&nbsp;Maral Ouzounian MD, PhD ,&nbsp;Charles Mve Mvondo MD","doi":"10.1016/j.xjon.2024.03.002","DOIUrl":"10.1016/j.xjon.2024.03.002","url":null,"abstract":"","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666273624000603/pdfft?md5=f5a4957ce040d73404d49e8ccb1e1691&pid=1-s2.0-S2666273624000603-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140278045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply: The art of winning an unfair game: Immediate aortic repair for mesenteric malperfusion syndrome 回复:赢得不公平游戏的艺术:肠系膜灌注不良综合征的即刻主动脉修补术
Pub Date : 2024-06-01 DOI: 10.1016/j.xjon.2024.04.013
James A. Brown MD, MS , Ibrahim Sultan MD
{"title":"Reply: The art of winning an unfair game: Immediate aortic repair for mesenteric malperfusion syndrome","authors":"James A. Brown MD, MS ,&nbsp;Ibrahim Sultan MD","doi":"10.1016/j.xjon.2024.04.013","DOIUrl":"10.1016/j.xjon.2024.04.013","url":null,"abstract":"","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666273624001165/pdfft?md5=5ede001a5889f1a8537059923d79d0a8&pid=1-s2.0-S2666273624001165-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140775020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
POBS-Card, a new score of severe bleeding after cardiac surgery: Construction and external validation POBS-CARD:心脏手术后严重出血的新评分标准:构建与外部验证
Pub Date : 2024-06-01 DOI: 10.1016/j.xjon.2024.04.008
Emmanuel Besnier MD, PhD , Pierre Schmidely MD , Guillaume Dubois MD , Prisca Lemonne MD , Lucie Todesco MD , Chadi Aludaat MD , Thierry Caus MD, PHD , Jean Selim MD, PhD , Emmanuel Lorne MD, PhD , Osama Abou-Arab MD, PhD

Objective

Bleeding after cardiac surgery leads to poor outcomes. The objective of the study was to build the PeriOperative Bleeding Score in Cardiac surgery (POBS-Card) to predict bleeding after cardiac surgery.

Methods

We conducted a retrospective cohort study in 2 academic hospitals (2016-2019). Inclusion criteria were adult patients after cardiac surgery under cardiopulmonary bypass. Exclusion criteria were heart transplantation, assistance, aortic dissection, and preoperative hemostasis diseases. Bleeding was defined by the universal definition for perioperative bleeding score ≥2. POBS-Card score was built using multivariate regression (derivation cohort, one center). The performance diagnosis was assessed using the area under the curve in a validation cohort (2 centers) and compared with other scores.

Results

In total, 1704 patients were included in the derivation cohort, 344 (20%) with bleeding. Preoperative factors were body mass index <25 kg/m2 (odds ratio [OR], 1.48 [1.14-1.93]), type of surgery (redo: OR, 1.76 [1.07-2.82]; combined: OR, 1.81 [1.19-2.74]; ascendant aorta: OR, 1.56 [1.02-2.38]), ongoing antiplatelet therapy (single: OR, 1.50 [1.09-2.05]; double: OR, 2.00 [1.15-3.37]), activated thromboplastin time ratio >1.2 (OR, 1.44 [1.03-1.99]), prothrombin ratio <60% (OR, 1.91 [1.21-2.97]), platelet count <150 g/L (OR, 1.74 [1.17-2.57]), and fibrinogen <3 g/L (OR, 1.33 [1.02-1.73]). In the validation cohort of 597 patients, the area under the curve was 0.645 [0.605-0.683] and was superior to other scores (WILL-BLEED, Papworth, TRUST, TRACK). A threshold >14 predicted bleeding with a sensitivity of 50% and a specificity of 73%.

Conclusions

POBS-Card score was superior to other scores in predicting severe bleeding after cardiac surgery. Performances remained modest, questioning the place of these scores in the perioperative strategy of bleeding-sparing.

目的心脏手术后出血会导致不良预后。该研究旨在建立心脏手术术前出血评分(POBS-Card),以预测心脏手术后的出血情况。方法我们在两家学术医院开展了一项回顾性队列研究(2016-2019 年)。纳入标准为在心肺旁路下进行心脏手术的成年患者。排除标准为心脏移植、辅助、主动脉夹层和术前止血疾病。出血按围手术期出血评分≥2的通用定义定义。POBS-Card 评分通过多元回归法得出(衍生队列,一个中心)。在验证队列(2 个中心)中使用曲线下面积评估了性能诊断,并与其他评分进行了比较。术前因素包括体重指数<25 kg/m2(几率比[OR],1.48 [1.14-1.93])、手术类型(重做:OR,1.76 [1.07-2.82];合并手术:OR,1.81 [1.19-2.74];升主动脉:OR,1.56 [1.02-2.38])、正在进行的抗血小板治疗(单次:OR,1.50 [1.09-2.05];双次:OR,2.00 [1.15-3.37])、活化凝血活酶时间比值>1.2(OR,1.44 [1.03-1.99])、凝血酶原比率<60%(OR,1.91 [1.21-2.97])、血小板计数<150 g/L(OR,1.74 [1.17-2.57])和纤维蛋白原<3 g/L(OR,1.33 [1.02-1.73])。在由 597 名患者组成的验证队列中,曲线下面积为 0.645 [0.605-0.683],优于其他评分(WILL-BLEED、Papworth、TRUST、TRACK)。结论POBS-Card 评分在预测心脏手术后严重出血方面优于其他评分。结论POBS-Card评分在预测心脏手术后严重出血方面优于其他评分,但其表现仍然一般,这对这些评分在围手术期预防出血策略中的地位提出了质疑。
{"title":"POBS-Card, a new score of severe bleeding after cardiac surgery: Construction and external validation","authors":"Emmanuel Besnier MD, PhD ,&nbsp;Pierre Schmidely MD ,&nbsp;Guillaume Dubois MD ,&nbsp;Prisca Lemonne MD ,&nbsp;Lucie Todesco MD ,&nbsp;Chadi Aludaat MD ,&nbsp;Thierry Caus MD, PHD ,&nbsp;Jean Selim MD, PhD ,&nbsp;Emmanuel Lorne MD, PhD ,&nbsp;Osama Abou-Arab MD, PhD","doi":"10.1016/j.xjon.2024.04.008","DOIUrl":"10.1016/j.xjon.2024.04.008","url":null,"abstract":"<div><h3>Objective</h3><p>Bleeding after cardiac surgery leads to poor outcomes. The objective of the study was to build the PeriOperative Bleeding Score in Cardiac surgery (POBS-Card) to predict bleeding after cardiac surgery.</p></div><div><h3>Methods</h3><p>We conducted a retrospective cohort study in 2 academic hospitals (2016-2019). Inclusion criteria were adult patients after cardiac surgery under cardiopulmonary bypass. Exclusion criteria were heart transplantation, assistance, aortic dissection, and preoperative hemostasis diseases. Bleeding was defined by the universal definition for perioperative bleeding score ≥2. POBS-Card score was built using multivariate regression (derivation cohort, one center). The performance diagnosis was assessed using the area under the curve in a validation cohort (2 centers) and compared with other scores.</p></div><div><h3>Results</h3><p>In total, 1704 patients were included in the derivation cohort, 344 (20%) with bleeding. Preoperative factors were body mass index &lt;25 kg/m<sup>2</sup> (odds ratio [OR], 1.48 [1.14-1.93]), type of surgery (redo: OR, 1.76 [1.07-2.82]; combined: OR, 1.81 [1.19-2.74]; ascendant aorta: OR, 1.56 [1.02-2.38]), ongoing antiplatelet therapy (single: OR, 1.50 [1.09-2.05]; double: OR, 2.00 [1.15-3.37]), activated thromboplastin time ratio &gt;1.2 (OR, 1.44 [1.03-1.99]), prothrombin ratio &lt;60% (OR, 1.91 [1.21-2.97]), platelet count &lt;150 g/L (OR, 1.74 [1.17-2.57]), and fibrinogen &lt;3 g/L (OR, 1.33 [1.02-1.73]). In the validation cohort of 597 patients, the area under the curve was 0.645 [0.605-0.683] and was superior to other scores (WILL-BLEED, Papworth, TRUST, TRACK). A threshold &gt;14 predicted bleeding with a sensitivity of 50% and a specificity of 73%.</p></div><div><h3>Conclusions</h3><p>POBS-Card score was superior to other scores in predicting severe bleeding after cardiac surgery. Performances remained modest, questioning the place of these scores in the perioperative strategy of bleeding-sparing.</p></div>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666273624001104/pdfft?md5=4b42f2c29a6781090215a943bfd8bbb0&pid=1-s2.0-S2666273624001104-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140756817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current definitions of hemodynamic structural valve deterioration after bioprosthetic aortic valve replacement lack consistency 目前对生物人工主动脉瓣置换术后血流动力学结构性瓣膜恶化的定义缺乏一致性
Pub Date : 2024-06-01 DOI: 10.1016/j.xjon.2024.02.023
Bart J.J. Velders MD , Michiel D. Vriesendorp MD, PhD , Federico M. Asch MD , Michael J. Reardon MD , Francois Dagenais MD , Michael G. Moront MD , Joseph F. Sabik III MD , Rolf H.H. Groenwold MD, PhD , Robert J.M. Klautz MD, PhD

Objective

New echocardiographic definitions have been proposed for hemodynamic structural valve deterioration. We aimed to study their consistency in classifying structural valve deterioration after surgical aortic valve replacement.

Methods

Data were used of patients undergoing surgical aortic valve replacement in a multicenter, prospective cohort study with a 5-year follow-up. All patients received the same stented bioprosthesis. Echocardiographic parameters were assessed by an independent core laboratory. Moderate or greater stenotic hemodynamic structural valve deterioration was defined according to Capodanno and colleagues, Dvir and colleagues, and the Valve Academic Research Consortium 3; regurgitation data were not considered in this analysis. Consistency was quantified on the basis of structural valve deterioration classification at subsequent time points.

Results

A total of 1118 patients received implants. Patients’ mean age was 70 years, and 75% were male. Hemodynamic structural valve deterioration at any visit was present in 51 patients (4.6%), 32 patients (2.9%), and 34 patients (3.0%) according to Capodanno, Dvir, and Valve Academic Research Consortium 3. A total of 1064 patients (95%) were never labeled with structural valve deterioration by any definition. After the first classification with structural valve deterioration, 59%, 59%, and 65% had no subsequent structural valve deterioration classification according to Capodanno, Dvir, and Valve Academic Research Consortium 3, respectively.

Conclusions

The current definitions of hemodynamic structural valve deterioration are strong negative predictors but inconsistent positive discriminators for the detection of stenotic hemodynamic structural valve deterioration. Although the diagnosis of structural valve deterioration may be categorical, echocardiographic indices lack this degree of precision in the first 5 years after surgical aortic valve replacement. The inconsistency of current structural valve deterioration definitions impedes the detection of true valve degeneration, which challenges the clinical usefulness of these definitions.

目的 对血流动力学结构性瓣膜恶化提出了新的超声心动图定义。我们的目的是研究这些定义在手术主动脉瓣置换术后结构性瓣膜恶化分类中的一致性。方法 在一项多中心、前瞻性队列研究中,对接受手术主动脉瓣置换术的患者进行了为期 5 年的随访。所有患者都接受了相同的支架生物假体。超声心动图参数由独立的核心实验室进行评估。根据Capodanno及其同事、Dvir及其同事和瓣膜学术研究联盟3对中度或更严重的狭窄血流动力学结构性瓣膜恶化进行了定义;本分析不考虑反流数据。根据后续时间点的结构性瓣膜恶化分类对一致性进行量化。患者的平均年龄为 70 岁,75% 为男性。根据 Capodanno、Dvir 和 Valve Academic Research Consortium 3 的分类,51 名患者(4.6%)、32 名患者(2.9%)和 34 名患者(3.0%)在任何一次就诊时均出现血流动力学结构性瓣膜恶化。共有 1064 名患者(95%)从未被任何定义标记为结构性瓣膜恶化。根据 Capodanno、Dvir 和瓣膜学术研究联盟 3,在首次进行结构性瓣膜恶化分类后,分别有 59%、59% 和 65% 的患者没有进行后续的结构性瓣膜恶化分类。虽然结构性瓣膜恶化的诊断可以分类,但在主动脉瓣置换术后的头 5 年中,超声心动图指标缺乏这种精确度。目前结构性瓣膜退化定义的不一致性阻碍了对真正瓣膜退化的检测,这对这些定义的临床实用性提出了挑战。
{"title":"Current definitions of hemodynamic structural valve deterioration after bioprosthetic aortic valve replacement lack consistency","authors":"Bart J.J. Velders MD ,&nbsp;Michiel D. Vriesendorp MD, PhD ,&nbsp;Federico M. Asch MD ,&nbsp;Michael J. Reardon MD ,&nbsp;Francois Dagenais MD ,&nbsp;Michael G. Moront MD ,&nbsp;Joseph F. Sabik III MD ,&nbsp;Rolf H.H. Groenwold MD, PhD ,&nbsp;Robert J.M. Klautz MD, PhD","doi":"10.1016/j.xjon.2024.02.023","DOIUrl":"10.1016/j.xjon.2024.02.023","url":null,"abstract":"<div><h3>Objective</h3><p>New echocardiographic definitions have been proposed for hemodynamic structural valve deterioration. We aimed to study their consistency in classifying structural valve deterioration after surgical aortic valve replacement.</p></div><div><h3>Methods</h3><p>Data were used of patients undergoing surgical aortic valve replacement in a multicenter, prospective cohort study with a 5-year follow-up. All patients received the same stented bioprosthesis. Echocardiographic parameters were assessed by an independent core laboratory. Moderate or greater stenotic hemodynamic structural valve deterioration was defined according to Capodanno and colleagues, Dvir and colleagues, and the Valve Academic Research Consortium 3; regurgitation data were not considered in this analysis. Consistency was quantified on the basis of structural valve deterioration classification at subsequent time points.</p></div><div><h3>Results</h3><p>A total of 1118 patients received implants. Patients’ mean age was 70 years, and 75% were male. Hemodynamic structural valve deterioration at any visit was present in 51 patients (4.6%), 32 patients (2.9%), and 34 patients (3.0%) according to Capodanno, Dvir, and Valve Academic Research Consortium 3. A total of 1064 patients (95%) were never labeled with structural valve deterioration by any definition. After the first classification with structural valve deterioration, 59%, 59%, and 65% had no subsequent structural valve deterioration classification according to Capodanno, Dvir, and Valve Academic Research Consortium 3, respectively.</p></div><div><h3>Conclusions</h3><p>The current definitions of hemodynamic structural valve deterioration are strong negative predictors but inconsistent positive discriminators for the detection of stenotic hemodynamic structural valve deterioration. Although the diagnosis of structural valve deterioration may be categorical, echocardiographic indices lack this degree of precision in the first 5 years after surgical aortic valve replacement. The inconsistency of current structural valve deterioration definitions impedes the detection of true valve degeneration, which challenges the clinical usefulness of these definitions.</p></div>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666273624000597/pdfft?md5=b09e5cceb462850bc2444a7be1282d40&pid=1-s2.0-S2666273624000597-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140274921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Noncomplex ventricular arrhythmia associated with greater freedom from recurrent ectopy at 1 year after mitral repair surgery 二尖瓣修复手术后 1 年,非复杂性室性心律失常与较高的复发性异位自由度相关。
Pub Date : 2024-06-01 DOI: 10.1016/j.xjon.2024.04.005
Dimosthenis Pandis MD, MSc , Navindra David BS , Ahmed EI-Eshmawi MD , Marc A. Miller MD , Percy Boateng MD , Ana Claudia Costa MD, PhD , Philip Robson PhD , Maria Giovanna Trivieri MD , Zahi Fayad PhD , Anelechi C. Anyanwu MD, MSc , David H. Adams MD

Objective

The effect of mitral valve (MV) surgery on the natural history of ventricular arrhythmia (VA) in patients with arrhythmic MV prolapse remains unknown. We sought to evaluate the cumulative incidence of VA at 1 year after surgical mitral repair.

Methods

A retrospective review of progressively captured data identified 204 consecutive patients who underwent elective MV repair for significant degenerative mitral regurgitation as a first-time cardiovascular intervention in a quaternary reference center between January 2018 and December 2020. A subset of 62 consecutive patients with diagnosed arrhythmic MV prolapse was further evaluated for recurrent VA after MV repair.

Results

The median age was 62 years (range, 27-77 years) and 26 of 62 (41.9%) were female. The median time from initial mitral regurgitation/MV prolaspe diagnosis-to-referral was 13.8 years (interquartile range [IQR], 5.4-25) and from VA diagnosis-to-referral was 8 years (IQR, 3-10.6). Using the Lown-Wolf classification, complex VA (Lown grade ≥3) was identified in 36 of 62 patients (58%) at baseline, whereas 8 of 62 (13%) had a cardioverter/defibrillator implanted for primary (4/8) or secondary (4/8) prevention. Left ventricular myocardial scar was confirmed in 23 of 34 (68%) of patients scanned at baseline. The prevailing valve phenotype was bileaflet Barlow (59/62; 95.2%). All patients underwent surgical MV repair by the same team. Surgical repair was stabilized with an annuloplasty prosthesis (median size 36 mm [IQR, 34-38]). Concomitant procedures included tricuspid valve repair (51/62; 82.3%), cryo-maze ± left atrial appendage exclusion (14/62, 23%), and endocardial cryoablation of VA ectopy (4/62; 6.5%). The 30-day and 1-year freedom from recurrent VA were 98.4% and 75.9%, respectively. Absent VA after mitral repair was uniformly observed in patients with minor VA at baseline. Absent VA after mitral repair was uniformly observed in patients with minor VA preoperatively. Complex baseline VA was the strongest predictor of recurrent VA (hazard ratio, 10.8; 95% confidence interval, 1.4-84.2; P = .024), irrespective of myocardial fibrosis.

Conclusions

In a series of 62 consecutive patients operated electively for arrhythmic mitral prolapse, VA remained undetected in 75.9% of patients at 1 year. Freedom from recurrent VA was greater among patients without complex VA preoperatively, whereas baseline Lown grade ≥3 was the strongest independent risk factor for recurrent VA at 1 year. These findings attest to the importance of early recognition and prompt referral of patients with mitral prolapse and progressive VA to specialty interdisciplinary care.

目的二尖瓣手术对心律失常性二尖瓣脱垂患者室性心律失常(VA)自然史的影响仍不清楚。我们试图评估二尖瓣手术修复后 1 年的室性心律失常累积发生率。方法回顾性审查逐步获取的数据,确定了 2018 年 1 月至 2020 年 12 月期间在一家四级参考中心首次接受心血管干预的 204 名连续患者,这些患者因显著退行性二尖瓣反流接受了选择性二尖瓣修复术。对62名确诊为心律失常二尖瓣脱垂的连续患者子集进行了进一步评估,以确定二尖瓣修复术后是否复发二尖瓣反流。从最初诊断二尖瓣反流/中上叶增生到转诊的中位时间为13.8年(四分位距[IQR],5.4-25),从诊断出VA到转诊的中位时间为8年(IQR,3-10.6)。根据 Lown-Wolf 分级法,62 名患者中有 36 人(58%)在基线时发现了复杂的 VA(Lown 分级≥3),62 人中有 8 人(13%)植入了心脏转复/除颤器,用于一级预防(4/8)或二级预防(4/8)。在基线扫描的 34 位患者中,有 23 位(68%)确认存在左心室心肌瘢痕。主要瓣膜表型为双叶巴洛瓣(59/62;95.2%)。所有患者都由同一个团队进行了中风瓣膜手术修复。手术修复时使用瓣环成形假体(中位尺寸为 36 毫米 [IQR,34-38])。同时进行的手术包括三尖瓣修复术(51/62;82.3%)、低温迷宫±左房阑尾切除术(14/62,23%)和VA异位的心内膜低温消融术(4/62;6.5%)。30天和1年内不再复发VA的比例分别为98.4%和75.9%。二尖瓣修复术后无VA的情况在基线时有轻微VA的患者中普遍存在。二尖瓣修复术后无VA的患者术前均有轻度VA。复杂基线VA是复发性VA的最强预测因素(危险比,10.8;95%置信区间,1.4-84.2;P = .024),与心肌纤维化无关。术前无复杂VA的患者更易复发VA,而基线Lown分级≥3是1年后复发VA的最强独立风险因素。这些研究结果证明了早期识别二尖瓣脱垂和进行性VA患者并及时转诊至专科跨学科治疗的重要性。
{"title":"Noncomplex ventricular arrhythmia associated with greater freedom from recurrent ectopy at 1 year after mitral repair surgery","authors":"Dimosthenis Pandis MD, MSc ,&nbsp;Navindra David BS ,&nbsp;Ahmed EI-Eshmawi MD ,&nbsp;Marc A. Miller MD ,&nbsp;Percy Boateng MD ,&nbsp;Ana Claudia Costa MD, PhD ,&nbsp;Philip Robson PhD ,&nbsp;Maria Giovanna Trivieri MD ,&nbsp;Zahi Fayad PhD ,&nbsp;Anelechi C. Anyanwu MD, MSc ,&nbsp;David H. Adams MD","doi":"10.1016/j.xjon.2024.04.005","DOIUrl":"10.1016/j.xjon.2024.04.005","url":null,"abstract":"<div><h3>Objective</h3><p>The effect of mitral valve (MV) surgery on the natural history of ventricular arrhythmia (VA) in patients with arrhythmic MV prolapse remains unknown. We sought to evaluate the cumulative incidence of VA at 1 year after surgical mitral repair.</p></div><div><h3>Methods</h3><p>A retrospective review of progressively captured data identified 204 consecutive patients who underwent elective MV repair for significant degenerative mitral regurgitation as a first-time cardiovascular intervention in a quaternary reference center between January 2018 and December 2020. A subset of 62 consecutive patients with diagnosed arrhythmic MV prolapse was further evaluated for recurrent VA after MV repair.</p></div><div><h3>Results</h3><p>The median age was 62 years (range, 27-77 years) and 26 of 62 (41.9%) were female. The median time from initial mitral regurgitation/MV prolaspe diagnosis-to-referral was 13.8 years (interquartile range [IQR], 5.4-25) and from VA diagnosis-to-referral was 8 years (IQR, 3-10.6). Using the Lown-Wolf classification, complex VA (Lown grade ≥3) was identified in 36 of 62 patients (58%) at baseline, whereas 8 of 62 (13%) had a cardioverter/defibrillator implanted for primary (4/8) or secondary (4/8) prevention. Left ventricular myocardial scar was confirmed in 23 of 34 (68%) of patients scanned at baseline. The prevailing valve phenotype was bileaflet Barlow (59/62; 95.2%). All patients underwent surgical MV repair by the same team. Surgical repair was stabilized with an annuloplasty prosthesis (median size 36 mm [IQR, 34-38]). Concomitant procedures included tricuspid valve repair (51/62; 82.3%), cryo-maze ± left atrial appendage exclusion (14/62, 23%), and endocardial cryoablation of VA ectopy (4/62; 6.5%). The 30-day and 1-year freedom from recurrent VA were 98.4% and 75.9%, respectively. Absent VA after mitral repair was uniformly observed in patients with minor VA at baseline. Absent VA after mitral repair was uniformly observed in patients with minor VA preoperatively. Complex baseline VA was the strongest predictor of recurrent VA (hazard ratio, 10.8; 95% confidence interval, 1.4-84.2; <em>P</em> = .024), irrespective of myocardial fibrosis.</p></div><div><h3>Conclusions</h3><p>In a series of 62 consecutive patients operated electively for arrhythmic mitral prolapse, VA remained undetected in 75.9% of patients at 1 year. Freedom from recurrent VA was greater among patients without complex VA preoperatively, whereas baseline Lown grade ≥3 was the strongest independent risk factor for recurrent VA at 1 year. These findings attest to the importance of early recognition and prompt referral of patients with mitral prolapse and progressive VA to specialty interdisciplinary care.</p></div>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666273624001074/pdfft?md5=654dde242501a48612881a9d15e1694d&pid=1-s2.0-S2666273624001074-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140771302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient-specific and organ-centric approach in malperfusion in acute type A dissection 急性 A 型夹层中灌注不良的患者特异性和器官中心方法
Pub Date : 2024-06-01 DOI: 10.1016/j.xjon.2024.04.002
Bashisth Mishra Mch , Simiyu R. Namungu MMED , Abdifatah A. Mohamed MD
{"title":"Patient-specific and organ-centric approach in malperfusion in acute type A dissection","authors":"Bashisth Mishra Mch ,&nbsp;Simiyu R. Namungu MMED ,&nbsp;Abdifatah A. Mohamed MD","doi":"10.1016/j.xjon.2024.04.002","DOIUrl":"10.1016/j.xjon.2024.04.002","url":null,"abstract":"","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666273624001049/pdfft?md5=57653fce47760fd7e905da7c0c7bb4a2&pid=1-s2.0-S2666273624001049-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140781329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JTCVS open
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1